Cagrilitide (10mg)

Many researchers stack Retatrutide with Cagrilintide. Cagrilintide is an investigational, long-acting acylated analog of the pancreatic hormone amylin, designed for biochemical research into metabolic regulation.¹ As a non-selective dual agonist, it targets both amylin (AMYR) and calcitonin (CTR) receptors.² Research models indicate that its molecular structure—modified with a ³$C_{20}$ fatty diacid—extends its biological half-life significantly compared to native amylin.⁴ In in vitro and animal studies, cagrilintide demonstrates potent effects on satiety signaling and gastric emptying, providing a valuable tool for exploring advanced peptide-based metabolic pathways